BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6243372)

  • 1. Urine calcitonin levels in patients with bronchogenic carcinoma.
    Becker KL; Nash DR; Silva OL; Snider RH; Moore CF
    JAMA; 1980 Feb; 243(7):670-2. PubMed ID: 6243372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
    Becker KL; Snider RH; Silva OL; Moore CF
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum calcitonin levels in bronchogenic cancer.
    Silva OL; Becker KL; Primack A; Doppman JL; Snider RH
    Chest; 1976 Apr; 69(4):495-9. PubMed ID: 177250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
    Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
    J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types.
    Winkelmann W; Deuss U; Allolio B; Hummerich W; Kaulen D; Brosch H; Guyot A; Arnold C
    Klin Wochenschr; 1984 Nov; 62(21):1018-24. PubMed ID: 6096627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin as a marker for bronchogenic cancer: a prospective study.
    Silva OL; Broder LE; Doppman JL; Snider RH; Moore CF; Cohen MH; Becker KL
    Cancer; 1979 Aug; 44(2):680-4. PubMed ID: 476577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic hormones in lung cancer patients at diagnosis and during therapy.
    Gropp C; Havemann K; Scheuer A
    Cancer; 1980 Jul; 46(2):347-54. PubMed ID: 6248192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demonstration of immunoreactive calcitonin in sera of lung cancer and COPD patients].
    Chen CF; Yiin KT; Chiang CD; Wang SJ; Lin WH; Guu CT; Jih KS; Lin TM; Huang WL
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 May; 41(5):367-74. PubMed ID: 3219649
    [No Abstract]   [Full Text] [Related]  

  • 10. [The serum levels of human calcitonin (hCT) and salmon calcitonin (sCT) in lung cancer patients].
    Yiin KT; Chiang CD; Chen CF; Wang SJ; Lin WH; Guu CJ; Lee HK; Jih KS; Lin TM; Huang WL
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Dec; 40(6):517-22. PubMed ID: 3502872
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of the calcitonin radioimmunoassay.
    Wood WG; Müller OA; Stalla G; Scriba PC
    J Clin Chem Clin Biochem; 1979 Dec; 17(12):781-7. PubMed ID: 547038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
    Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
    Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorials: elevated plasma calcitonin as a marker for bronchogenic carcinoma.
    Williams GA
    Chest; 1976 Apr; 69(4):451. PubMed ID: 1261308
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
    Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
    Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis in human bronchogenic carcinoma.
    Peterson HI; Larsson S; Zettergren L
    Bibl Anat; 1975; 13():315-6. PubMed ID: 182114
    [No Abstract]   [Full Text] [Related]  

  • 16. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcitonin as a marker for bronchial carcinoma (author's transl)].
    Gropp C; Havemann K; Pflüger KH
    Dtsch Med Wochenschr; 1980 Aug; 105(34):1175-8. PubMed ID: 6257466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent elevation of plasma ACTH in patients with bronchogenic carcinoma.
    Davis S; May PB
    Am J Med Sci; 1982; 283(1):2-7. PubMed ID: 6275702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
    Roof BS; Weinstein R; Vujic I; Burdash NM
    Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha-subunit of human chorionic gonadotropin in bronchogenic carcinoma].
    Zatloukal P; Glagolicová A; Mĕricka O; Bezdícek P
    Sb Lek; 1993; 94(4):327-31. PubMed ID: 7527586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.